We are live on !
Find out more
Longaeva Partners Portfolio holdings
AUM
$4.58B
Turnover
75.17%
1-Year Est. Return
43.91%
This Fund
S&P 500
This Quarter Est. Return
+20.82%
1 Year Est. Return
+43.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.58B
AUM Growth
+$1.88B
(+69%)
Cap. Flow
+$1.03B
Cap. Flow % of AUM
Cap. Flow %
22.6%
Top 10 Holdings %
Top 10 Hldgs %
29.9%
Holding
435
New
231
Increased
47
Reduced
58
Closed
96
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$101M |
| 2 |
JPMorgan Chase
JPM
|
+$79.2M |
| 3 |
Moody's
MCO
|
+$58.8M |
| 4 |
Fifth Third Bancorp
FITB
|
+$58.5M |
| 5 |
LPL Financial
LPLA
|
+$56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$68M |
| 2 |
ACM Research
ACMR
|
+$48.8M |
| 3 |
Citizens Financial Group
CFG
|
+$47.1M |
| 4 |
Vishay Intertechnology
VSH
|
+$46.3M |
| 5 |
Goldman Sachs
GS
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.82% |
| 2 | Financials | 20.39% |
| 3 | Healthcare | 17.29% |
| 4 | Industrials | 14.57% |
| 5 | Technology | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Philip Morris
PM
$311B
| $3.83M | 0.08% |
+21,153
| New | +$3.67M |
2026 Q2
0 quarters
|
|
202
Manhattan Associates
MANH
$13.9B
| $3.78M | 0.08% |
+27,176
| New | +$3.74M |
2026 Q2
0 quarters
|
|
203
Pool Corp
POOL
$7.23B
| $3.76M | 0.08% |
+17,481
| New | +$3.49M |
2026 Q2
0 quarters
|
|
204
General Motors
GM
$64.5B
| $3.75M | 0.08% |
+48,683
| New | +$3.82M |
2026 Q2
0 quarters
|
|
205
Ultra Clean Holdings
UCTT
$2.05B
| $3.75M | 0.08% |
26,305
-18,699
| -42% | -$1.65M |
2026 Q1
1 quarter
|
|
206
Compass
COMP
$7.48B
| $3.7M | 0.08% |
+300,000
| New | +$2.5M |
2026 Q2
0 quarters
|
|
207
CVS Health
CVS
$120B
| $3.7M | 0.08% |
+35,732
| New | +$3.19M |
2026 Q2
0 quarters
|
|
208
EXL Service
EXLS
$6.41B
| $3.68M | 0.08% |
+142,246
| New | +$4.19M |
2026 Q2
0 quarters
|
|
209
Blackstone
BX
$94.1B
| $3.65M | 0.08% |
+31,032
| New | +$3.73M |
2026 Q2
0 quarters
|
|
210
Marriott International
MAR
$102B
| $3.61M | 0.08% |
9,748
-12,352
| -56% | -$4.56M |
2025 Q4
2 quarters
|
|
211
Pacific Biosciences
PACB
$656M
| $3.56M | 0.08% |
+2,118,231
| New | +$3.08M |
2026 Q2
0 quarters
|
|
212
Applied Industrial Technologies
AIT
$11.6B
| $3.55M | 0.08% |
+10,508
| New | +$3.22M |
2026 Q2
0 quarters
|
|
213
Broadcom
AVGO
$1.54T
| $3.5M | 0.08% |
+9,270
| New | +$3.72M |
2026 Q2
0 quarters
|
|
214
Everpure Inc
P
$41.1B
| $3.47M | 0.08% |
+44,087
| New | +$3.23M |
2026 Q2
0 quarters
|
|
215
Delek US
DK
$4.56B
| $3.4M | 0.07% |
+66,914
| New | +$2.97M |
2026 Q2
0 quarters
|
|
216
Federal Signal
FSS
$6.91B
| $3.38M | 0.07% |
+26,325
| New | +$3.02M |
2026 Q2
0 quarters
|
|
217
Repligen
RGEN
$11.2B
| $3.36M | 0.07% |
+24,616
| New | +$3.02M |
2026 Q2
0 quarters
|
|
218
MasTec
MTZ
$13.7B
| $3.32M | 0.07% |
7,968
-5,046
| -39% | -$1.93M |
2026 Q1
1 quarter
|
|
219
Valvoline
VVV
$4.04B
| $3.27M | 0.07% |
+82,777
| New | +$2.88M |
2026 Q2
0 quarters
|
|
220
Lantheus
LNTH
$6.52B
| $3.22M | 0.07% |
29,051
-354,894
| -92% | -$33.1M |
2026 Q1
1 quarter
|
|
221
Exponent
EXPO
$3.68B
| $3.19M | 0.07% |
+54,254
| New | +$3.33M |
2026 Q2
0 quarters
|
|
222
MoonLake Immunotherapeutics
MLTX
$1.01B
| $3.15M | 0.07% |
161,557
-248,443
| -61% | -$4.5M |
2026 Q1
1 quarter
|
|
223
EQT Corp
EQT
$34.8B
| $3.09M | 0.07% |
+58,113
| New | +$3.26M |
2026 Q2
0 quarters
|
|
224
Coca-Cola
KO
$399B
| $3.02M | 0.07% |
+37,215
| New | +$2.94M |
2026 Q2
0 quarters
|
|
225
Acadia Pharmaceuticals
ACAD
$3.4B
| $2.97M | 0.06% |
+117,318
| New | +$2.58M |
2026 Q2
0 quarters
|
|
Similar funds
BWA
Longaeva Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Longaeva Partners held 435 positions worth $4.58B, up 69% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Longaeva Partners deployed $1.03B of net new capital in Q2 2026, opening 231 new positions and adding to 47 existing holdings. Its largest new stake was SpaceX: 596,829 shares worth $102M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ACM Research, an estimated $48.8M trimmed.
- Longaeva Partners's largest Q2 2026 buy was SpaceX: 596,829 shares worth $102M.
- Longaeva Partners added most to Mettler-Toledo International in Q2 2026, an estimated $39.4M increase.
- Longaeva Partners's biggest Q2 2026 reduction was ACM Research, cutting an estimated $48.8M.
- Longaeva Partners fully exited PNC Financial Services in Q2 2026, selling an estimated $68M.
- Longaeva Partners's ten largest holdings make up 30% of its $4.58B portfolio in Q2 2026.
- Longaeva Partners opened 231 new positions and closed 96 in Q2 2026.
- Longaeva Partners's portfolio value rose 69% quarter-over-quarter to $4.58B.
Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.